PlexusDx prescribers screen for contraindications and monitor your health throughout treatment
Both medications cause nausea, diarrhea or constipation, decreased appetite, and occasional injection site reactions
The prescribing note should include: the patient's current HbA1c or BMI with date of measurement, a chronological list of all prior therapies with dates and reasons for discontinuation, a statement of why liraglutide specifically is preferred over other non-preferred agents (for example, the cardiovascular outcome benefit documented in LEADER [5] for a patient with known coronary artery disease), and a direct reference to the applicable ADA or Endocrine Society guideline recommendation [6][8]
To assess potential predictive factors, baseline characteristics were compared between Responder and Non-Responder patients by unpaired Student t test
Establish a regular eating schedule within a consistent window each day, ideally 12 hours